Executive Director, Metabolism & Obesity
MSD
About this role
The Executive Director of Metabolism & Obesity will lead research efforts in metabolic diseases, obesity, and related co-morbidities within the Cardiometabolic Disease Discovery Biology Department at a South San Francisco research center. The role contributes to strategic planning and integration of new technology platforms, human biology, and data science to drive high-quality drug discovery. The position is with a research-driven biopharmaceutical company focused on inventing medicines and vaccines.
Skills
Qualifications
About MSD
msd.comAt MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Recent company news
MSD reaffirms long-term commitment to Vietnam's healthcare sector
3 hours ago
ASCO GU: How Merck & Co/MSD is Advancing Treatment of Bladder and Kidney Cancers
3 weeks ago
Louisville Water Company, MSD honor 96 veterans during annual breakfast
Nov 7, 2025
MSD ends takeover talks with Revolution Medicines
1 month ago
Exclusive Interview with BDT & MSD Partners Co-CEOs
Nov 19, 2025
About MSD
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for MSD.
Salary
$255k – $402k
per year
More jobs at MSD
Similar Jobs
Senior Scientist, In Vivo Metabolism Bioscience
AstraZeneca
Senior Scientist, In Vivo Metabolism Bioscience
AstraZeneca
Scientist - Immunology
Eli Lilly and Company
Physician Scientist – Obesity and Liver Disease Human Genetics
Regeneron Pharmaceuticals
Associate Scientist, In Vivo & In Vitro
Regeneron Pharmaceuticals
Discovery Scientist in Cardiovascular & Metabolism Preclinical Research -2 years temporary contract
Roche